Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Roby_Zomer
|
| gptkbp:country |
gptkb:Australia
|
| gptkbp:focus |
cannabinoid-based medicines
|
| gptkbp:foundedYear |
2014
|
| gptkbp:headquartersLocation |
gptkb:Perth,_Australia
|
| https://www.w3.org/2000/01/rdf-schema#label |
MGC Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:listedOn |
gptkb:London_Stock_Exchange
gptkb:Australian_Securities_Exchange |
| gptkbp:product |
gptkb:ArtemiC
gptkb:CannEpil gptkb:CogniCann |
| gptkbp:stockExchange |
gptkb:ASX
|
| gptkbp:stockSymbol |
gptkb:MXC
|
| gptkbp:website |
https://mgcpharma.com.au/
|
| gptkbp:bfsParent |
gptkb:MGC
|
| gptkbp:bfsLayer |
6
|